Key Immune Cells Predict Recurrence in Lung Cancer Patients
Patients treated surgically for early-stage lung cancer face an increased risk of recurrence if their tumors contain a large number of cells that act as “dimmer switches” on the immune system, according to a study at Duke University Medical Center.
This entry was posted on Wednesday, December 27th, 2006 at 5:19 pm and is filed under Research. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.